Last reviewed · How we verify

NCT07406737: FORGE CSP

Feasibility and Outcomes Registry of Lumenless dEfibrillation Leads for Conduction System Pacing

Not yet recruiting Last updated 12 February 2026
What this trial tests

trial in Cardiac Resynchronization Therapy in 200 participants. Not yet recruiting.

Timeline
1 May 2026
Primary endpoint
1 May 2027
1 September 2027

Quick facts

Lead sponsorUniversity Hospital, Caen
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment200
Start date1 May 2026
Primary completion1 May 2027
Estimated completion1 September 2027
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Caen

Who can join

18 and older, any sex, with Cardiac Resynchronization Therapy or Left Bundle Branch Area Pacing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The recent development and market introduction of small diameter implantable defibrillation leads able to deliver left bundle branch area pacing (LBBAP) has opened the possibility of achieving cardiac resynchronization therapy (CRT) using a single- or dual-chamber implantable-cardioverter defibrillator (ICD). This approach may reduce the number of intracardiac leads required and, consequently, has the potential to lower both procedural and long-term complication rates. However, the integration of these leads into currently recommended CRT strategies remains hypothetical. The FORGE CSP registry will prospectively enroll patients with an indication for CRT in whom implantation of a LBBAP ICD lead is attempted.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiac Resynchronization Therapy

Currently open trials in the same condition.

Other University Hospital, Caen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07406737.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing